nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—Walking disability—Capecitabine—esophageal cancer	0.0392	0.164	CcSEcCtD
Perhexiline—Papilloedema—Cisplatin—esophageal cancer	0.0193	0.0806	CcSEcCtD
Perhexiline—Cachexia—Capecitabine—esophageal cancer	0.0158	0.0661	CcSEcCtD
Perhexiline—Polyneuropathy—Capecitabine—esophageal cancer	0.0139	0.058	CcSEcCtD
Perhexiline—Optic neuritis—Cisplatin—esophageal cancer	0.00997	0.0417	CcSEcCtD
Perhexiline—Balance disorder—Capecitabine—esophageal cancer	0.00827	0.0346	CcSEcCtD
Perhexiline—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00787	0.0329	CcSEcCtD
Perhexiline—Liver injury—Cisplatin—esophageal cancer	0.00729	0.0305	CcSEcCtD
Perhexiline—Blood triglycerides increased—Capecitabine—esophageal cancer	0.0069	0.0288	CcSEcCtD
Perhexiline—Torsade de pointes—Capecitabine—esophageal cancer	0.00645	0.0269	CcSEcCtD
Perhexiline—Hepatocellular injury—Cisplatin—esophageal cancer	0.00613	0.0256	CcSEcCtD
Perhexiline—Gait disturbance—Capecitabine—esophageal cancer	0.00463	0.0194	CcSEcCtD
Perhexiline—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00336	0.0141	CcSEcCtD
Perhexiline—Diplopia—Capecitabine—esophageal cancer	0.00328	0.0137	CcSEcCtD
Perhexiline—Ataxia—Capecitabine—esophageal cancer	0.00309	0.0129	CcSEcCtD
Perhexiline—Muscular weakness—Capecitabine—esophageal cancer	0.00289	0.0121	CcSEcCtD
Perhexiline—Flushing—Cisplatin—esophageal cancer	0.00286	0.0119	CcSEcCtD
Perhexiline—Weight decreased—Capecitabine—esophageal cancer	0.00257	0.0107	CcSEcCtD
Perhexiline—Tremor—Cisplatin—esophageal cancer	0.00251	0.0105	CcSEcCtD
Perhexiline—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00248	0.0104	CcSEcCtD
Perhexiline—Convulsion—Cisplatin—esophageal cancer	0.00232	0.00971	CcSEcCtD
Perhexiline—Ataxia—Methotrexate—esophageal cancer	0.0023	0.0096	CcSEcCtD
Perhexiline—Hepatitis—Capecitabine—esophageal cancer	0.00227	0.00949	CcSEcCtD
Perhexiline—Hyperhidrosis—Cisplatin—esophageal cancer	0.00212	0.00884	CcSEcCtD
Perhexiline—Flushing—Capecitabine—esophageal cancer	0.00211	0.00881	CcSEcCtD
Perhexiline—Anorexia—Cisplatin—esophageal cancer	0.00209	0.00872	CcSEcCtD
Perhexiline—Paraesthesia—Cisplatin—esophageal cancer	0.00196	0.00821	CcSEcCtD
Perhexiline—Decreased appetite—Cisplatin—esophageal cancer	0.0019	0.00795	CcSEcCtD
Perhexiline—Tremor—Capecitabine—esophageal cancer	0.00185	0.00774	CcSEcCtD
Perhexiline—Sweating—Methotrexate—esophageal cancer	0.0018	0.00754	CcSEcCtD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0018	0.00237	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—ADH7—esophageal cancer	0.00178	0.00234	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BLVRB—esophageal cancer	0.00178	0.00234	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC52A3—esophageal cancer	0.00178	0.00234	CbGpPWpGaD
Perhexiline—Syncope—Capecitabine—esophageal cancer	0.00177	0.00741	CcSEcCtD
Perhexiline—Loss of consciousness—Capecitabine—esophageal cancer	0.00174	0.00726	CcSEcCtD
Perhexiline—Hepatitis—Methotrexate—esophageal cancer	0.00169	0.00706	CcSEcCtD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00167	0.0022	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00165	0.00217	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ADH1B—esophageal cancer	0.00163	0.00214	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00159	0.0021	CbGpPWpGaD
Perhexiline—Shock—Capecitabine—esophageal cancer	0.00159	0.00663	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00157	0.00207	CbGpPWpGaD
Perhexiline—Asthenia—Cisplatin—esophageal cancer	0.00157	0.00656	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—ADH1B—esophageal cancer	0.00156	0.00206	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Capecitabine—esophageal cancer	0.00156	0.00652	CcSEcCtD
Perhexiline—CPT2—Metabolism—TYMP—esophageal cancer	0.00156	0.00205	CbGpPWpGaD
Perhexiline—Anorexia—Capecitabine—esophageal cancer	0.00154	0.00643	CcSEcCtD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00153	0.00202	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00153	0.00201	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC10A2—esophageal cancer	0.00152	0.00199	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP26A1—esophageal cancer	0.00152	0.00199	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CA1—esophageal cancer	0.00152	0.00199	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00151	0.00199	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00148	0.00194	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALOX15—esophageal cancer	0.00148	0.00194	CbGpPWpGaD
Perhexiline—Insomnia—Capecitabine—esophageal cancer	0.00146	0.0061	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—CYP26A1—esophageal cancer	0.00145	0.00191	CbGpPWpGaD
Perhexiline—Paraesthesia—Capecitabine—esophageal cancer	0.00145	0.00605	CcSEcCtD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00144	0.0019	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00144	0.00189	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00143	0.00189	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00143	0.00188	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TPI1—esophageal cancer	0.00141	0.00185	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTO1—esophageal cancer	0.00141	0.00185	CbGpPWpGaD
Perhexiline—Decreased appetite—Capecitabine—esophageal cancer	0.0014	0.00586	CcSEcCtD
Perhexiline—Vomiting—Cisplatin—esophageal cancer	0.00139	0.00581	CcSEcCtD
Perhexiline—Fatigue—Capecitabine—esophageal cancer	0.00139	0.00581	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CA2—esophageal cancer	0.00139	0.00182	CbGpPWpGaD
Perhexiline—Rash—Cisplatin—esophageal cancer	0.00138	0.00577	CcSEcCtD
Perhexiline—Dermatitis—Cisplatin—esophageal cancer	0.00138	0.00576	CcSEcCtD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00136	0.00178	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00136	0.00178	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTO1—esophageal cancer	0.00135	0.00178	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALDOB—esophageal cancer	0.00135	0.00178	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00135	0.00177	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00134	0.00176	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00133	0.00175	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00133	0.00175	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00132	0.00551	CcSEcCtD
Perhexiline—CPT2—Metabolism—GAPDH—esophageal cancer	0.0013	0.00171	CbGpPWpGaD
Perhexiline—Nausea—Cisplatin—esophageal cancer	0.0013	0.00543	CcSEcCtD
Perhexiline—CPT1A—Metabolism—PLCE1—esophageal cancer	0.00129	0.00169	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ADH7—esophageal cancer	0.00129	0.00169	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CRABP1—esophageal cancer	0.00129	0.00169	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00129	0.00169	CbGpPWpGaD
Perhexiline—Urticaria—Capecitabine—esophageal cancer	0.00128	0.00535	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.00128	0.00168	CbGpPWpGaD
Perhexiline—Abdominal pain—Capecitabine—esophageal cancer	0.00128	0.00533	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—esophageal cancer	0.00127	0.00533	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00127	0.00168	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00127	0.00167	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00125	0.00164	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00124	0.00164	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.00124	0.00163	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GNG7—esophageal cancer	0.00123	0.00161	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.0012	0.00158	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—EP300—esophageal cancer	0.00117	0.00154	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Methotrexate—esophageal cancer	0.00116	0.00485	CcSEcCtD
Perhexiline—Asthenia—Capecitabine—esophageal cancer	0.00116	0.00484	CcSEcCtD
Perhexiline—CPT2—Metabolism—ALDH2—esophageal cancer	0.00115	0.00151	CbGpPWpGaD
Perhexiline—Anorexia—Methotrexate—esophageal cancer	0.00114	0.00478	CcSEcCtD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00114	0.0015	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ADH1B—esophageal cancer	0.00113	0.00149	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—ALDH2—esophageal cancer	0.0011	0.00145	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00109	0.00144	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTT1—esophageal cancer	0.00109	0.00144	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00109	0.00144	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00109	0.00143	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.00109	0.00143	CbGpPWpGaD
Perhexiline—Insomnia—Methotrexate—esophageal cancer	0.00109	0.00454	CcSEcCtD
Perhexiline—CPT1A—Metabolism—TYMP—esophageal cancer	0.00108	0.00142	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP2A6—esophageal cancer	0.00108	0.00142	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00108	0.00142	CbGpPWpGaD
Perhexiline—Paraesthesia—Methotrexate—esophageal cancer	0.00108	0.00451	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00108	0.00141	CbGpPWpGaD
Perhexiline—Dizziness—Capecitabine—esophageal cancer	0.00107	0.00446	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CYP26A1—esophageal cancer	0.00105	0.00138	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTT1—esophageal cancer	0.00105	0.00138	CbGpPWpGaD
Perhexiline—Decreased appetite—Methotrexate—esophageal cancer	0.00104	0.00436	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—CYP2A6—esophageal cancer	0.00104	0.00136	CbGpPWpGaD
Perhexiline—Fatigue—Methotrexate—esophageal cancer	0.00104	0.00433	CcSEcCtD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00103	0.00135	CbGpPWpGaD
Perhexiline—Vomiting—Capecitabine—esophageal cancer	0.00103	0.00429	CcSEcCtD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00102	0.00135	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ENO1—esophageal cancer	0.00102	0.00135	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS1—esophageal cancer	0.00102	0.00135	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALOX15—esophageal cancer	0.00102	0.00135	CbGpPWpGaD
Perhexiline—Rash—Capecitabine—esophageal cancer	0.00102	0.00425	CcSEcCtD
Perhexiline—Dermatitis—Capecitabine—esophageal cancer	0.00102	0.00425	CcSEcCtD
Perhexiline—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.00101	0.00133	CbGpPWpGaD
Perhexiline—Headache—Capecitabine—esophageal cancer	0.00101	0.00422	CcSEcCtD
Perhexiline—CPT2—Metabolism—PSME2—esophageal cancer	0.00101	0.00133	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PSME1—esophageal cancer	0.00101	0.00133	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000997	0.00131	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—PTGS1—esophageal cancer	0.000982	0.00129	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000982	0.0041	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GSTO1—esophageal cancer	0.000977	0.00128	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TPI1—esophageal cancer	0.000977	0.00128	CbGpPWpGaD
Perhexiline—Nausea—Capecitabine—esophageal cancer	0.000958	0.004	CcSEcCtD
Perhexiline—Urticaria—Methotrexate—esophageal cancer	0.000954	0.00399	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—esophageal cancer	0.000949	0.00397	CcSEcCtD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000943	0.00124	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.00094	0.00124	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALDOB—esophageal cancer	0.000937	0.00123	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000927	0.00122	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GAPDH—esophageal cancer	0.000902	0.00119	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CRABP1—esophageal cancer	0.000894	0.00117	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000886	0.00117	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000881	0.00116	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000881	0.00116	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP1B1—esophageal cancer	0.000871	0.00114	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00087	0.00114	CbGpPWpGaD
Perhexiline—Asthenia—Methotrexate—esophageal cancer	0.000861	0.0036	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GNG7—esophageal cancer	0.00085	0.00112	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00084	0.0011	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—esophageal cancer	0.000836	0.0011	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP1B1—esophageal cancer	0.000835	0.0011	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000829	0.00109	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000824	0.00108	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP19A1—esophageal cancer	0.000819	0.00108	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000818	0.00108	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000811	0.00107	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALDH2—esophageal cancer	0.000796	0.00105	CbGpPWpGaD
Perhexiline—Dizziness—Methotrexate—esophageal cancer	0.000794	0.00332	CcSEcCtD
Perhexiline—CYP2B6—Biological oxidations—CYP19A1—esophageal cancer	0.000785	0.00103	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000774	0.00102	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000766	0.00101	CbGpPWpGaD
Perhexiline—Vomiting—Methotrexate—esophageal cancer	0.000763	0.00319	CcSEcCtD
Perhexiline—CPT1A—Metabolism—GSTT1—esophageal cancer	0.000758	0.000996	CbGpPWpGaD
Perhexiline—Rash—Methotrexate—esophageal cancer	0.000757	0.00316	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—esophageal cancer	0.000756	0.00316	CcSEcCtD
Perhexiline—Headache—Methotrexate—esophageal cancer	0.000752	0.00314	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CYP2A6—esophageal cancer	0.000749	0.000984	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—HMOX1—esophageal cancer	0.000747	0.000982	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000746	0.000981	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000733	0.000963	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000729	0.000958	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.00072	0.000947	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—esophageal cancer	0.000717	0.000943	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000714	0.000939	CbGpPWpGaD
Perhexiline—Nausea—Methotrexate—esophageal cancer	0.000713	0.00298	CcSEcCtD
Perhexiline—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000711	0.000934	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ENO1—esophageal cancer	0.00071	0.000933	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS1—esophageal cancer	0.00071	0.000933	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PSME2—esophageal cancer	0.0007	0.00092	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PSME1—esophageal cancer	0.0007	0.00092	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000683	0.000897	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000672	0.000883	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000661	0.000869	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000652	0.000857	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000614	0.000808	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000611	0.000803	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000606	0.000796	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP1B1—esophageal cancer	0.000604	0.000793	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000581	0.000763	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000573	0.000753	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP19A1—esophageal cancer	0.000568	0.000746	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000546	0.000717	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000542	0.000713	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000538	0.000708	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—HMOX1—esophageal cancer	0.000518	0.000681	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000508	0.000668	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000501	0.000658	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—esophageal cancer	0.000497	0.000653	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CREBBP—esophageal cancer	0.000479	0.00063	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000476	0.000626	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000471	0.000619	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000446	0.000587	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NOS3—esophageal cancer	0.000429	0.000564	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BLVRB—esophageal cancer	0.000422	0.000555	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC52A3—esophageal cancer	0.000422	0.000555	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—esophageal cancer	0.000392	0.000516	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00038	0.000499	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000376	0.000494	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000374	0.000492	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA1—esophageal cancer	0.000359	0.000472	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC10A2—esophageal cancer	0.000359	0.000472	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000357	0.000469	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000352	0.000463	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CREBBP—esophageal cancer	0.000332	0.000437	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA2—esophageal cancer	0.000328	0.000431	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—EP300—esophageal cancer	0.000326	0.000429	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PLCE1—esophageal cancer	0.000305	0.000401	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000305	0.000401	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NOS3—esophageal cancer	0.000297	0.000391	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000293	0.000386	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000293	0.000386	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—esophageal cancer	0.000272	0.000358	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000268	0.000352	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMP—esophageal cancer	0.000256	0.000336	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA1—esophageal cancer	0.000249	0.000328	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000249	0.000328	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000249	0.000327	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALOX15—esophageal cancer	0.000242	0.000319	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—esophageal cancer	0.000241	0.000317	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TPI1—esophageal cancer	0.000231	0.000304	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTO1—esophageal cancer	0.000231	0.000304	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA2—esophageal cancer	0.000228	0.0003	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—esophageal cancer	0.000226	0.000297	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALDOB—esophageal cancer	0.000222	0.000291	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GAPDH—esophageal cancer	0.000213	0.00028	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000212	0.000279	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000212	0.000279	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CRABP1—esophageal cancer	0.000211	0.000278	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GNG7—esophageal cancer	0.000201	0.000264	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000192	0.000252	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000192	0.000252	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALDH2—esophageal cancer	0.000188	0.000248	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000186	0.000244	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—esophageal cancer	0.000179	0.000236	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000178	0.000234	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2A6—esophageal cancer	0.000177	0.000233	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000173	0.000227	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000168	0.000221	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ENO1—esophageal cancer	0.000168	0.000221	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS1—esophageal cancer	0.000168	0.000221	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—esophageal cancer	0.000167	0.00022	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PSME2—esophageal cancer	0.000166	0.000218	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PSME1—esophageal cancer	0.000166	0.000218	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000163	0.000214	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA1—esophageal cancer	0.000163	0.000214	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000161	0.000211	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000161	0.000211	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000154	0.000203	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA2—esophageal cancer	0.000149	0.000196	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000148	0.000195	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000147	0.000193	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP1B1—esophageal cancer	0.000143	0.000188	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GNG7—esophageal cancer	0.00014	0.000184	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000139	0.000182	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000139	0.000182	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP19A1—esophageal cancer	0.000134	0.000177	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000131	0.000172	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000125	0.000164	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000123	0.000162	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—HMOX1—esophageal cancer	0.000123	0.000161	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000122	0.00016	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—esophageal cancer	0.000118	0.000155	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000117	0.000153	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000117	0.000153	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000116	0.000153	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000115	0.000151	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000115	0.000151	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000113	0.000149	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.00011	0.000145	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000105	0.000138	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000105	0.000138	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000101	0.000132	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP1B1—esophageal cancer	9.93e-05	0.000131	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.7e-05	0.000127	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.61e-05	0.000126	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP19A1—esophageal cancer	9.33e-05	0.000123	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GNG7—esophageal cancer	9.14e-05	0.00012	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.56e-05	0.000113	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—HMOX1—esophageal cancer	8.52e-05	0.000112	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.18e-05	0.000107	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.15e-05	0.000107	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.05e-05	0.000106	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CREBBP—esophageal cancer	7.86e-05	0.000103	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.63e-05	0.0001	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ENO1—esophageal cancer	7.63e-05	0.0001	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSME1—esophageal cancer	7.52e-05	9.89e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PSME2—esophageal cancer	7.52e-05	9.89e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NOS3—esophageal cancer	7.04e-05	9.25e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.49e-05	8.53e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—esophageal cancer	6.44e-05	8.46e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.1e-05	8.02e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.57e-05	7.32e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.46e-05	7.18e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—esophageal cancer	5.35e-05	7.04e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.34e-05	7.03e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NOS3—esophageal cancer	4.89e-05	6.43e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.47e-05	5.88e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.96e-05	5.21e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—esophageal cancer	3.72e-05	4.89e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.57e-05	4.7e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NOS3—esophageal cancer	3.2e-05	4.2e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.93e-05	3.85e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.75e-05	3.62e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—esophageal cancer	2.43e-05	3.2e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.8e-05	2.37e-05	CbGpPWpGaD
